Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALPG | P10696 | 2/20 | 0.66 |
| ▸ | ALPI | P09923 | 1/20 | 0.66 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.66 |
| ▸ | PLAA | Q9Y263 | 1/20 | 0.66 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.66 |
| ▸ | CYP19A1 | P11511 | 6/20 | 0.61 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.60 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.60 |
| ▸ | CA12 | O43570 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | CA3 | P07451 | 1/20 | 0.55 |
| ▸ | CA4 | P22748 | 1/20 | 0.55 |
| ▸ | CA6 | P23280 | 1/20 | 0.55 |
| ▸ | CA5A | P35218 | 1/20 | 0.55 |
| ▸ | CA7 | P43166 | 1/20 | 0.55 |
| ▸ | CA9 | Q16790 | 1/20 | 0.55 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.55 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.55 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nafimidone SCHEMBL29861032 | 0.99 | ALPG (0.67) | ALPGALPITDP1PLAAL3MBTL1 | |
| Nafimidone SCHEMBL412582 | 0.99 | ALPG (0.67) | ALPGALPITDP1PLAAL3MBTL1 | |
| Nafimidone SCHEMBL11356554 | 0.97 | ALPG (0.63) | ALPGALPITDP1PLAAL3MBTL1 | |
| Nafimidone SCHEMBL11355091 | 0.92 | ALPG (0.57) | ALPGALPITDP1PLAAL3MBTL1 | |
| SCHEMBL11481042 | 0.87 | ALPG (0.68) | ALPGALPITDP1PLAAL3MBTL1 | |
| Hydrochloric Acid SCHEMBL11190595 | 0.86 | ALPG (0.65) | ALPGALPITDP1PLAAL3MBTL1 | |
| Hydrochloric Acid SCHEMBL11181980 | 0.86 | ALPG (0.69) | ALPGALPITDP1PLAAL3MBTL1 | |
| SCHEMBL11474959 | 0.86 | ALPG (0.63) | ALPGALPITDP1PLAAL3MBTL1 | |
| SCHEMBL11188512 | 0.86 | ALPG (0.63) | ALPGALPITDP1PLAAL3MBTL1 | |
| SCHEMBL10974263 | 0.86 | ALPG (0.63) | ALPGALPITDP1PLAAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| CN-101330905-A | Freeze-drying process and products obtained thereby | SCIDOSE LLC (US) | 2008-12-24 | — | — | CN | claimed |
| EP-1954244-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | Scidose, Llc (US) | 2008-08-13 | — | — | EP | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| EP-1175209-A2 | USE OF ANTIEPILEPTICS FOR TREATING RESPIRATORY DISORDERS, IN PARTICULAR ASTHMATIC DISORDERS | Lomia, Merab (GE) | 2002-01-30 | — | — | EP | claimed |
| WO-2000066096-A2 | USE OF ANTIEPILEPTICS FOR TREATING RESPIRATORY DISORDERS, IN PARTICULAR ASTHMATIC DISORDERS | LOMIA MERAB (GE) | 2000-11-09 | — | — | WO | claimed |
| US-4150153-A | ANTICONVULSANTS, GASTRIC ANTISECRETORY AGENTS | SYNTEX (U.S.A.) INC. (US) | 1979-04-17 | — | — | US | claimed |
| CN-109320458-B | Diaryl imidazole-containing compound, preparation method and medical application thereof | 中国药科大学 | 2022-05-31 | — | — | CN | disclosed |
| US-20220047505-A1 | Controlled Absorption Water-Soluble Pharmaceutically Active Organic Compound Formulation for Once-Daily Administration | STI PHARMA, LLC (US) | 2022-02-17 | — | — | US | disclosed |
| US-11191719-B2 | Controlled absorption water-soluble pharmaceutically active organic compound formulation for once-daily administration | STI PHARMA, LLC (US) | 2021-12-07 | — | — | US | disclosed |
| US-20210134398-A1 | Combinatorial Chemistry Computational System and Enhanced Selection Method | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2021-05-06 | — | — | US | disclosed |
| US-10463611-B2 | Controlled absorption water-soluble pharmaceutically active organic compound formulation for once-daily administration | STI PHARMA, LLC (US) | 2019-11-05 | — | — | US | disclosed |
| EP-0001926-B1 | 1-(NAPHTHYLETHYL)IMIDAZOLE DERIVATIVES, THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SYNTEX (U.S.A.) INC. (US) | 1981-04-29 | — | — | EP | disclosed |
| US-4246274-A | MICROBIOCIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1981-01-20 | — | — | US | disclosed |
| EP-0011769-A1 | Hydroxyethyl azoles, process for their preparation and their use in medicaments | BAYER AG (DE) | 1980-06-11 | — | — | EP | disclosed |
| EP-0001926-A1 | 1-(Naphthylethyl)imidazole derivatives, their preparation, and pharmaceutical compositions containing them | SYNTEX (U.S.A.) INC. (US) | 1979-05-16 | — | — | EP | disclosed |
| US-4150153-A | ANTICONVULSANTS, GASTRIC ANTISECRETORY AGENTS | SYNTEX (U.S.A.) INC. (US) | 1979-04-17 | — | — | US | disclosed |
| US-4124767-A | Imidazolyl-oxime ethers having anti-mycotic and bactericidal activity | SIEGFRIED A.G. (CH) | 1978-11-07 | — | — | US | disclosed |